If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> Volume 109 Number 1 JANuArY 2014<br /> www.amjgastro.com<br /> official publication of the american college of gastroenterology<br /> leading articles of the month<br /> Clinical and Systematic Reviews<br /> 23 The Role of Thiopurines in Reducing the Need for Surgical<br /> Resection in Crohn’s Disease: A Systematic Review<br /> and Meta-Analysis CME<br /> S. Chatu, V. Subramanian, S. Saxena and R.C.G. Pollok<br /> Esophagus<br /> 52 Objective Manometric Criteria for the Rumination Syndrome<br /> B.F. Kessing, A.J. Bredenoord and A.J.P.M. Smout<br /> Stomach<br /> 60 Effect of Helicobacter pylori Eradication on Metachronous<br /> Recurrence After Endoscopic Resection of Gastric Neoplasm<br /> S.E. Bae, H.-Y. Jung, J. Kang, Y.S. Park, S. Baek, J.-H. Jung, J.Y. Choi,<br /> M.-Y. Kim, J.Y. Ahn, K.-S. Choi, D.H. Kim, J.H. Lee, K.D. Cho<a title="AJG_Vol.109.No.8 page 1" href="http://viewer.zmags.com/publication/7f86916d?page=1"> ARCHIVE Volume 109 Number 1 JANuArY 2014 www.amj</a> <a title="AJG_Vol.109.No.8 page 2" href="http://viewer.zmags.com/publication/7f86916d?page=2"> VOLUME 109 NUMBER 8 AUGUST 2014 www.amjgastro.com</a> <a title="AJG_Vol.109.No.8 page 3" href="http://viewer.zmags.com/publication/7f86916d?page=3"> InActive,MildtoModerateUlcerativeColitis(UC) POWE</a> <a title="AJG_Vol.109.No.8 page 4" href="http://viewer.zmags.com/publication/7f86916d?page=4"> BRIEF SUMMARY UCERIS (budesonide) extended releas</a> <a title="AJG_Vol.109.No.8 page 5" href="http://viewer.zmags.com/publication/7f86916d?page=5"> official publication of the american college</a> <a title="AJG_Vol.109.No.8 page 6" href="http://viewer.zmags.com/publication/7f86916d?page=6"> </a> <a title="AJG_Vol.109.No.8 page 7" href="http://viewer.zmags.com/publication/7f86916d?page=7"> </a> <a title="AJG_Vol.109.No.8 page 8" href="http://viewer.zmags.com/publication/7f86916d?page=8"> www.amjgastro.com The American Journal of</a> <a title="AJG_Vol.109.No.8 page 9" href="http://viewer.zmags.com/publication/7f86916d?page=9"> References: 1. Li K, Foy E, Ferreon JC, et al. Im</a> <a title="AJG_Vol.109.No.8 page 10" href="http://viewer.zmags.com/publication/7f86916d?page=10"> HCV: Master of Elusion The human body does everyt</a> <a title="AJG_Vol.109.No.8 page 11" href="http://viewer.zmags.com/publication/7f86916d?page=11"> Save the Date! October 17–22, 2014 ACG2014 </a> <a title="AJG_Vol.109.No.8 page 12" href="http://viewer.zmags.com/publication/7f86916d?page=12"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.109.No.8 page 13" href="http://viewer.zmags.com/publication/7f86916d?page=13"> Lowest volume of active prep solution— only 10 oz</a> <a title="AJG_Vol.109.No.8 page 14" href="http://viewer.zmags.com/publication/7f86916d?page=14"> Top: High-power view of the antral mucosa biopsy </a> <a title="AJG_Vol.109.No.8 page 15" href="http://viewer.zmags.com/publication/7f86916d?page=15"> CONTENTS </a> <a title="AJG_Vol.109.No.8 page 16" href="http://viewer.zmags.com/publication/7f86916d?page=16"> www.amjgastro.com </a> <a title="AJG_Vol.109.No.8 page 17" href="http://viewer.zmags.com/publication/7f86916d?page=17"> Important Safety Information for HUMIRA® (adalimu</a> <a title="AJG_Vol.109.No.8 page 18" href="http://viewer.zmags.com/publication/7f86916d?page=18"> In patients with moderate to severe Crohn's disea</a> <a title="AJG_Vol.109.No.8 page 19" href="http://viewer.zmags.com/publication/7f86916d?page=19"> HUMIRA® (adalimumab) </a> <a title="AJG_Vol.109.No.8 page 20" href="http://viewer.zmags.com/publication/7f86916d?page=20"> Consider discontinuation of HUMIRA therapy in pat</a> <a title="AJG_Vol.109.No.8 page 21" href="http://viewer.zmags.com/publication/7f86916d?page=21"> other biologic DMARDS (e.g., anakinra and abatace</a> <a title="AJG_Vol.109.No.8 page 22" href="http://viewer.zmags.com/publication/7f86916d?page=22"> RetroView ™ GivesYouThe Power To See It. One loo</a> <a title="AJG_Vol.109.No.8 page 23" href="http://viewer.zmags.com/publication/7f86916d?page=23"> INDICATION SOVALDI is a hepatitis C virus (HCV) n</a> <a title="AJG_Vol.109.No.8 page 24" href="http://viewer.zmags.com/publication/7f86916d?page=24"> SOVALDI REGIMENS WERE STUDIED ACROSS MANY TYPES O</a> <a title="AJG_Vol.109.No.8 page 25" href="http://viewer.zmags.com/publication/7f86916d?page=25"> ADDITIONAL SUBJECTS STUDIED WITH SOVALDI REGIMENS</a> <a title="AJG_Vol.109.No.8 page 26" href="http://viewer.zmags.com/publication/7f86916d?page=26"> SOVALDI® (sofosbuvir) Brief summary of full Pre</a> <a title="AJG_Vol.109.No.8 page 27" href="http://viewer.zmags.com/publication/7f86916d?page=27"> Brief Summary (cont.) Table 2 Percentage of Subj</a> <a title="AJG_Vol.109.No.8 page 28" href="http://viewer.zmags.com/publication/7f86916d?page=28"> Setting the standard in quality improvement initi</a> <a title="AJG_Vol.109.No.8 page 29" href="http://viewer.zmags.com/publication/7f86916d?page=29"> Delivering symptomatic relief to IBS sufferers for</a> <a title="AJG_Vol.109.No.8 page 30" href="http://viewer.zmags.com/publication/7f86916d?page=30"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 31" href="http://viewer.zmags.com/publication/7f86916d?page=31"> 1126 THE RED SECTION </a> <a title="AJG_Vol.109.No.8 page 32" href="http://viewer.zmags.com/publication/7f86916d?page=32"> THE RED SECTION 1127 What’s Hot in the RED J</a> <a title="AJG_Vol.109.No.8 page 33" href="http://viewer.zmags.com/publication/7f86916d?page=33"> 1128 THE RED SECTION </a> <a title="AJG_Vol.109.No.8 page 34" href="http://viewer.zmags.com/publication/7f86916d?page=34"> Privacy and security rules. The Privacy Rule prov</a> <a title="AJG_Vol.109.No.8 page 35" href="http://viewer.zmags.com/publication/7f86916d?page=35"> 1130 THE RED SECTION physicians must place</a> <a title="AJG_Vol.109.No.8 page 36" href="http://viewer.zmags.com/publication/7f86916d?page=36"> medical students should be aware that online post</a> <a title="AJG_Vol.109.No.8 page 37" href="http://viewer.zmags.com/publication/7f86916d?page=37"> 1132 THE RED SECTION 14. U.S. Department of</a> <a title="AJG_Vol.109.No.8 page 38" href="http://viewer.zmags.com/publication/7f86916d?page=38"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 39" href="http://viewer.zmags.com/publication/7f86916d?page=39"> 1134 THE RED SECTION is logical that fatig</a> <a title="AJG_Vol.109.No.8 page 40" href="http://viewer.zmags.com/publication/7f86916d?page=40"> Table 1. Patient demographic information On-call </a> <a title="AJG_Vol.109.No.8 page 41" href="http://viewer.zmags.com/publication/7f86916d?page=41"> 1136 THE RED SECTION of screening colonosc</a> <a title="AJG_Vol.109.No.8 page 42" href="http://viewer.zmags.com/publication/7f86916d?page=42"> approved the final draft submitted. Patrick Pfau:</a> <a title="AJG_Vol.109.No.8 page 43" href="http://viewer.zmags.com/publication/7f86916d?page=43"> 1138 THE RED SECTION </a> <a title="AJG_Vol.109.No.8 page 44" href="http://viewer.zmags.com/publication/7f86916d?page=44"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 45" href="http://viewer.zmags.com/publication/7f86916d?page=45"> 1140 PRACTICE GUIDELINES </a> <a title="AJG_Vol.109.No.8 page 46" href="http://viewer.zmags.com/publication/7f86916d?page=46"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 47" href="http://viewer.zmags.com/publication/7f86916d?page=47"> 1142 Wald et al. Defecatory disorder/d</a> <a title="AJG_Vol.109.No.8 page 48" href="http://viewer.zmags.com/publication/7f86916d?page=48"> 2. Gastroenterologists and other providers shoul</a> <a title="AJG_Vol.109.No.8 page 49" href="http://viewer.zmags.com/publication/7f86916d?page=49"> 1144 Wald et al. Table 1. Sensitivity and </a> <a title="AJG_Vol.109.No.8 page 50" href="http://viewer.zmags.com/publication/7f86916d?page=50"> Recommendations for the treatment of disordered d</a> <a title="AJG_Vol.109.No.8 page 51" href="http://viewer.zmags.com/publication/7f86916d?page=51"> 1146 Wald et al. Table 2. Biofeedback trea</a> <a title="AJG_Vol.109.No.8 page 52" href="http://viewer.zmags.com/publication/7f86916d?page=52"> Recommendations for diagnostic assessment 6. Gas</a> <a title="AJG_Vol.109.No.8 page 53" href="http://viewer.zmags.com/publication/7f86916d?page=53"> 1148 Wald et al. Table 3. Common causes of</a> <a title="AJG_Vol.109.No.8 page 54" href="http://viewer.zmags.com/publication/7f86916d?page=54"> symptoms are mild and not bothersome </a> <a title="AJG_Vol.109.No.8 page 55" href="http://viewer.zmags.com/publication/7f86916d?page=55"> 1150 Wald et al. Clinical evaluation incl</a> <a title="AJG_Vol.109.No.8 page 56" href="http://viewer.zmags.com/publication/7f86916d?page=56"> Recommendations for surgical treatment 15. Sacra</a> <a title="AJG_Vol.109.No.8 page 57" href="http://viewer.zmags.com/publication/7f86916d?page=57"> 1152 Wald et al. informed views toward th</a> <a title="AJG_Vol.109.No.8 page 58" href="http://viewer.zmags.com/publication/7f86916d?page=58"> this could become a stand-alone treatment or an a</a> <a title="AJG_Vol.109.No.8 page 59" href="http://viewer.zmags.com/publication/7f86916d?page=59"> 1154 Wald et al. 4. Gastroenterologists a</a> <a title="AJG_Vol.109.No.8 page 60" href="http://viewer.zmags.com/publication/7f86916d?page=60"> 6. Ratuapli S, Bharucha AE, Harvey D et al. Comp</a> <a title="AJG_Vol.109.No.8 page 61" href="http://viewer.zmags.com/publication/7f86916d?page=61"> 1156 Wald et al. 61. Leigh RJ, Turnberg L</a> <a title="AJG_Vol.109.No.8 page 62" href="http://viewer.zmags.com/publication/7f86916d?page=62"> 117. Mundy L, Merlin TL, Maddern GJ et al. System</a> <a title="AJG_Vol.109.No.8 page 63" href="http://viewer.zmags.com/publication/7f86916d?page=63"> 1158 PRACTICE GUIDELINES </a> <a title="AJG_Vol.109.No.8 page 64" href="http://viewer.zmags.com/publication/7f86916d?page=64"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 65" href="http://viewer.zmags.com/publication/7f86916d?page=65"> 1160 Giardiello et al. Table 1. Levels of </a> <a title="AJG_Vol.109.No.8 page 66" href="http://viewer.zmags.com/publication/7f86916d?page=66"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 67" href="http://viewer.zmags.com/publication/7f86916d?page=67"> 1162 Giardiello et al. Table 5. Amsterdam </a> <a title="AJG_Vol.109.No.8 page 68" href="http://viewer.zmags.com/publication/7f86916d?page=68"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 69" href="http://viewer.zmags.com/publication/7f86916d?page=69"> 1164 Giardiello et al. Table 7. Sensitivit</a> <a title="AJG_Vol.109.No.8 page 70" href="http://viewer.zmags.com/publication/7f86916d?page=70"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 71" href="http://viewer.zmags.com/publication/7f86916d?page=71"> 1166 Giardiello et al. Normal No further t</a> <a title="AJG_Vol.109.No.8 page 72" href="http://viewer.zmags.com/publication/7f86916d?page=72"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 73" href="http://viewer.zmags.com/publication/7f86916d?page=73"> 1168 Giardiello et al. </a> <a title="AJG_Vol.109.No.8 page 74" href="http://viewer.zmags.com/publication/7f86916d?page=74"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 75" href="http://viewer.zmags.com/publication/7f86916d?page=75"> 1170 Giardiello et al. Table 9. Studies of</a> <a title="AJG_Vol.109.No.8 page 76" href="http://viewer.zmags.com/publication/7f86916d?page=76"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 77" href="http://viewer.zmags.com/publication/7f86916d?page=77"> 1172 Giardiello et al. Table 11. Studies o</a> <a title="AJG_Vol.109.No.8 page 78" href="http://viewer.zmags.com/publication/7f86916d?page=78"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 79" href="http://viewer.zmags.com/publication/7f86916d?page=79"> 1174 Giardiello et al. for this guideline </a> <a title="AJG_Vol.109.No.8 page 80" href="http://viewer.zmags.com/publication/7f86916d?page=80"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 81" href="http://viewer.zmags.com/publication/7f86916d?page=81"> 1176 Giardiello et al. aspirin can decrea</a> <a title="AJG_Vol.109.No.8 page 82" href="http://viewer.zmags.com/publication/7f86916d?page=82"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 83" href="http://viewer.zmags.com/publication/7f86916d?page=83"> 1178 Giardiello et al. 83. Rustgi AK. Th</a> <a title="AJG_Vol.109.No.8 page 84" href="http://viewer.zmags.com/publication/7f86916d?page=84"> Guidelines on Genetic Evaluation and Management o</a> <a title="AJG_Vol.109.No.8 page 85" href="http://viewer.zmags.com/publication/7f86916d?page=85"> 1180 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109.No.8 page 86" href="http://viewer.zmags.com/publication/7f86916d?page=86"> IMPROVING PATIENT PROTECTION FROM RADIATION EXPOS</a> <a title="AJG_Vol.109.No.8 page 87" href="http://viewer.zmags.com/publication/7f86916d?page=87"> 1182 Ho et al. REVIEW Table 2. Adult effect</a> <a title="AJG_Vol.109.No.8 page 88" href="http://viewer.zmags.com/publication/7f86916d?page=88"> the United States and found that the volume of CT</a> <a title="AJG_Vol.109.No.8 page 89" href="http://viewer.zmags.com/publication/7f86916d?page=89"> 1184 Ho et al. REVIEW hospitalizations, as </a> <a title="AJG_Vol.109.No.8 page 90" href="http://viewer.zmags.com/publication/7f86916d?page=90"> 60 years (2,53). Incorporating these patient fact</a> <a title="AJG_Vol.109.No.8 page 91" href="http://viewer.zmags.com/publication/7f86916d?page=91"> 1186 Ho et al. REVIEW balloon catheter incr</a> <a title="AJG_Vol.109.No.8 page 92" href="http://viewer.zmags.com/publication/7f86916d?page=92"> the data. For those who do not have access to a c</a> <a title="AJG_Vol.109.No.8 page 93" href="http://viewer.zmags.com/publication/7f86916d?page=93"> 1188 Ho et al. REVIEW to patient size and s</a> <a title="AJG_Vol.109.No.8 page 94" href="http://viewer.zmags.com/publication/7f86916d?page=94"> Low-dose CT with iterative reconstruction. The af</a> <a title="AJG_Vol.109.No.8 page 95" href="http://viewer.zmags.com/publication/7f86916d?page=95"> 1190 Ho et al. REVIEW Quality control of flu</a> <a title="AJG_Vol.109.No.8 page 96" href="http://viewer.zmags.com/publication/7f86916d?page=96"> ity that provides the most complete and best-defi</a> <a title="AJG_Vol.109.No.8 page 97" href="http://viewer.zmags.com/publication/7f86916d?page=97"> 1192 Ho et al. REVIEW CONFLICT OF INTEREST </a> <a title="AJG_Vol.109.No.8 page 98" href="http://viewer.zmags.com/publication/7f86916d?page=98"> disease: a comparison with surgical histop</a> <a title="AJG_Vol.109.No.8 page 99" href="http://viewer.zmags.com/publication/7f86916d?page=99"> 1194 Ho et al. REVIEW Engineering, 7</a> <a title="AJG_Vol.109.No.8 page 100" href="http://viewer.zmags.com/publication/7f86916d?page=100"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 101" href="http://viewer.zmags.com/publication/7f86916d?page=101"> 1196 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109.No.8 page 102" href="http://viewer.zmags.com/publication/7f86916d?page=102"> extensively investigated (10). Other relevant neu</a> <a title="AJG_Vol.109.No.8 page 103" href="http://viewer.zmags.com/publication/7f86916d?page=103"> 1198 Kessing et al. Proximal Gas REVIE</a> <a title="AJG_Vol.109.No.8 page 104" href="http://viewer.zmags.com/publication/7f86916d?page=104"> Excessive Belching Symptoms 1199 Negative</a> <a title="AJG_Vol.109.No.8 page 105" href="http://viewer.zmags.com/publication/7f86916d?page=105"> 1200 Kessing et al. Proximal Gas Reflux</a> <a title="AJG_Vol.109.No.8 page 106" href="http://viewer.zmags.com/publication/7f86916d?page=106"> belches but an increased number of supragastric b</a> <a title="AJG_Vol.109.No.8 page 107" href="http://viewer.zmags.com/publication/7f86916d?page=107"> 1202 Kessing et al. REVIEW patients complai</a> <a title="AJG_Vol.109.No.8 page 108" href="http://viewer.zmags.com/publication/7f86916d?page=108"> 32. Rommel N, Tack J, Arts J et al. Rumination or</a> <a title="AJG_Vol.109.No.8 page 109" href="http://viewer.zmags.com/publication/7f86916d?page=109"> 1204 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109.No.8 page 110" href="http://viewer.zmags.com/publication/7f86916d?page=110"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 111" href="http://viewer.zmags.com/publication/7f86916d?page=111"> 1206 Lochhead et al. Exposure </a> <a title="AJG_Vol.109.No.8 page 112" href="http://viewer.zmags.com/publication/7f86916d?page=112"> Colorectal Neoplasia Molecular Pathological Epide</a> <a title="AJG_Vol.109.No.8 page 113" href="http://viewer.zmags.com/publication/7f86916d?page=113"> 1208 Lochhead et al. REVIEW APC, TP53, and </a> <a title="AJG_Vol.109.No.8 page 114" href="http://viewer.zmags.com/publication/7f86916d?page=114"> fragments of tissue, or may remain undetected, wh</a> <a title="AJG_Vol.109.No.8 page 115" href="http://viewer.zmags.com/publication/7f86916d?page=115"> 1210 Lochhead et al. REVIEW Second, th</a> <a title="AJG_Vol.109.No.8 page 116" href="http://viewer.zmags.com/publication/7f86916d?page=116"> REFERENCES 1. Lao VV, Grady WM. Epigenetics and </a> <a title="AJG_Vol.109.No.8 page 117" href="http://viewer.zmags.com/publication/7f86916d?page=117"> 1212 Lochhead et al. REVIEW 53. Ogino S, Fu</a> <a title="AJG_Vol.109.No.8 page 118" href="http://viewer.zmags.com/publication/7f86916d?page=118"> 104. Ogino S, Nosho K, Kirkner GJ et al. A cohort</a> <a title="AJG_Vol.109.No.8 page 119" href="http://viewer.zmags.com/publication/7f86916d?page=119"> 1214 Lochhead et al. REVIEW 155. With CM, E</a> <a title="AJG_Vol.109.No.8 page 120" href="http://viewer.zmags.com/publication/7f86916d?page=120"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 121" href="http://viewer.zmags.com/publication/7f86916d?page=121"> 1216 Verbeek et al. ESOPHAGUS Table 1. Char</a> <a title="AJG_Vol.109.No.8 page 122" href="http://viewer.zmags.com/publication/7f86916d?page=122"> Surveillance and Mortality in Esophageal Adenocar</a> <a title="AJG_Vol.109.No.8 page 123" href="http://viewer.zmags.com/publication/7f86916d?page=123"> 1218 Verbeek et al. 1.0 ESOPHAGUS Prob</a> <a title="AJG_Vol.109.No.8 page 124" href="http://viewer.zmags.com/publication/7f86916d?page=124"> Surveillance and Mortality in Esophageal Adenocar</a> <a title="AJG_Vol.109.No.8 page 125" href="http://viewer.zmags.com/publication/7f86916d?page=125"> 1220 Verbeek et al. ESOPHAGUS Table 2. Cont</a> <a title="AJG_Vol.109.No.8 page 126" href="http://viewer.zmags.com/publication/7f86916d?page=126"> observed trend of decreasing mortality rates that</a> <a title="AJG_Vol.109.No.8 page 127" href="http://viewer.zmags.com/publication/7f86916d?page=127"> 1222 Verbeek et al. ESOPHAGUS 13. Rubenstei</a> <a title="AJG_Vol.109.No.8 page 128" href="http://viewer.zmags.com/publication/7f86916d?page=128"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 129" href="http://viewer.zmags.com/publication/7f86916d?page=129"> 1224 Kim et al. LIVER patients with advance</a> <a title="AJG_Vol.109.No.8 page 130" href="http://viewer.zmags.com/publication/7f86916d?page=130"> + 1.5 *bilirubin ( > 18 µmol/l = 1, ≤18 µmol/l =</a> <a title="AJG_Vol.109.No.8 page 131" href="http://viewer.zmags.com/publication/7f86916d?page=131"> 1226 Kim et al. LIVER Table 1. Baseline cha</a> <a title="AJG_Vol.109.No.8 page 132" href="http://viewer.zmags.com/publication/7f86916d?page=132"> VR to ETV and HCC in HBV-Related Cirrhosis 122</a> <a title="AJG_Vol.109.No.8 page 133" href="http://viewer.zmags.com/publication/7f86916d?page=133"> 1228 Kim et al. LIVER Table 2. Risk factors</a> <a title="AJG_Vol.109.No.8 page 134" href="http://viewer.zmags.com/publication/7f86916d?page=134"> VR to ETV and HCC in HBV-Related Cirrhosis 122</a> <a title="AJG_Vol.109.No.8 page 135" href="http://viewer.zmags.com/publication/7f86916d?page=135"> 1230 Kim et al. LIVER Table 3. Risk factors</a> <a title="AJG_Vol.109.No.8 page 136" href="http://viewer.zmags.com/publication/7f86916d?page=136"> 1.0 0.8 0.6 Sensitivity 0.4 0.2 CU-HCC GA</a> <a title="AJG_Vol.109.No.8 page 137" href="http://viewer.zmags.com/publication/7f86916d?page=137"> 1232 Kim et al. LIVER other hand, in the pr</a> <a title="AJG_Vol.109.No.8 page 138" href="http://viewer.zmags.com/publication/7f86916d?page=138"> 11. Wong VW, Chan SL, Mo F et al. Clinical scorin</a> <a title="AJG_Vol.109.No.8 page 139" href="http://viewer.zmags.com/publication/7f86916d?page=139"> 1234 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.8 page 140" href="http://viewer.zmags.com/publication/7f86916d?page=140"> unsuitable for RFA because of various risks, incl</a> <a title="AJG_Vol.109.No.8 page 141" href="http://viewer.zmags.com/publication/7f86916d?page=141"> 1236 Kim et al. LIVER Statistical analysis </a> <a title="AJG_Vol.109.No.8 page 142" href="http://viewer.zmags.com/publication/7f86916d?page=142"> 1.0 Overall survival rates 0.8 0.6 0.4 0.</a> <a title="AJG_Vol.109.No.8 page 143" href="http://viewer.zmags.com/publication/7f86916d?page=143"> 1238 Kim et al. LIVER ever, HCCs that are l</a> <a title="AJG_Vol.109.No.8 page 144" href="http://viewer.zmags.com/publication/7f86916d?page=144"> CONFLICT OF INTEREST Guarantor of the article: Ji</a> <a title="AJG_Vol.109.No.8 page 145" href="http://viewer.zmags.com/publication/7f86916d?page=145"> 1240 Kim et al. LIVER 33. Ekelund L, Lin G,</a> <a title="AJG_Vol.109.No.8 page 146" href="http://viewer.zmags.com/publication/7f86916d?page=146"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 147" href="http://viewer.zmags.com/publication/7f86916d?page=147"> 1242 Lee et al. LIVER cavir (ETV) and tenof</a> <a title="AJG_Vol.109.No.8 page 148" href="http://viewer.zmags.com/publication/7f86916d?page=148"> antibody to HBeAg (anti-HBe) were measured using </a> <a title="AJG_Vol.109.No.8 page 149" href="http://viewer.zmags.com/publication/7f86916d?page=149"> 1244 Lee et al. LIVER Table 1. Baseline cha</a> <a title="AJG_Vol.109.No.8 page 150" href="http://viewer.zmags.com/publication/7f86916d?page=150"> Prediction of Liver-Related Events Using Transien</a> <a title="AJG_Vol.109.No.8 page 151" href="http://viewer.zmags.com/publication/7f86916d?page=151"> 1246 Lee et al. LIVER Table 3. Independent </a> <a title="AJG_Vol.109.No.8 page 152" href="http://viewer.zmags.com/publication/7f86916d?page=152"> was identified as an independent predictor of dev</a> <a title="AJG_Vol.109.No.8 page 153" href="http://viewer.zmags.com/publication/7f86916d?page=153"> 1248 Lee et al. LIVER ACKNOWLEDGMENTS The a</a> <a title="AJG_Vol.109.No.8 page 154" href="http://viewer.zmags.com/publication/7f86916d?page=154"> 27. Chen CJ, Yang HI, Su J et al. Risk of hepatoc</a> <a title="AJG_Vol.109.No.8 page 155" href="http://viewer.zmags.com/publication/7f86916d?page=155"> 1250 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109.No.8 page 156" href="http://viewer.zmags.com/publication/7f86916d?page=156"> INTRODUCTION Adalimumab (ADA, a fully human anti-</a> <a title="AJG_Vol.109.No.8 page 157" href="http://viewer.zmags.com/publication/7f86916d?page=157"> 1252 Roblin et al. INFLAMMATORY BOWEL DISEAS</a> <a title="AJG_Vol.109.No.8 page 158" href="http://viewer.zmags.com/publication/7f86916d?page=158"> Pharmacokinetics of Adalimumab in IBD 1253 Cl</a> <a title="AJG_Vol.109.No.8 page 159" href="http://viewer.zmags.com/publication/7f86916d?page=159"> 1254 Roblin et al. a 25 20 1</a> <a title="AJG_Vol.109.No.8 page 160" href="http://viewer.zmags.com/publication/7f86916d?page=160"> Table 4. Predictors of clinical remission after s</a> <a title="AJG_Vol.109.No.8 page 161" href="http://viewer.zmags.com/publication/7f86916d?page=161"> 1256 Roblin et al. INFLAMMATORY BOWEL DISEAS</a> <a title="AJG_Vol.109.No.8 page 162" href="http://viewer.zmags.com/publication/7f86916d?page=162"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 163" href="http://viewer.zmags.com/publication/7f86916d?page=163"> 1258 Kapidzic et al. COLON/SMALL BOWEL larg</a> <a title="AJG_Vol.109.No.8 page 164" href="http://viewer.zmags.com/publication/7f86916d?page=164"> Three Rounds of Population-Based FIT Screening </a> <a title="AJG_Vol.109.No.8 page 165" href="http://viewer.zmags.com/publication/7f86916d?page=165"> 1260 Kapidzic et al. First round </a> <a title="AJG_Vol.109.No.8 page 166" href="http://viewer.zmags.com/publication/7f86916d?page=166"> Three Rounds of Population-Based FIT Screening </a> <a title="AJG_Vol.109.No.8 page 167" href="http://viewer.zmags.com/publication/7f86916d?page=167"> 1262 Kapidzic et al. COLON/SMALL BOWEL afte</a> <a title="AJG_Vol.109.No.8 page 168" href="http://viewer.zmags.com/publication/7f86916d?page=168"> a strongly reduced risk of CRC compared with peop</a> <a title="AJG_Vol.109.No.8 page 169" href="http://viewer.zmags.com/publication/7f86916d?page=169"> 1264 Kapidzic et al. COLON/SMALL BOWEL 6. </a> <a title="AJG_Vol.109.No.8 page 170" href="http://viewer.zmags.com/publication/7f86916d?page=170"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 171" href="http://viewer.zmags.com/publication/7f86916d?page=171"> 1266 Feuerstadt et al. COLON/SMALL BOWEL IN</a> <a title="AJG_Vol.109.No.8 page 172" href="http://viewer.zmags.com/publication/7f86916d?page=172"> Charlson score For each patient, the Charlson com</a> <a title="AJG_Vol.109.No.8 page 173" href="http://viewer.zmags.com/publication/7f86916d?page=173"> 1268 Feuerstadt et al. COLON/SMALL BOWEL Ta</a> <a title="AJG_Vol.109.No.8 page 174" href="http://viewer.zmags.com/publication/7f86916d?page=174"> CDI 06–08 vs. 09–11 1269 Table 2. CA-CDI vs</a> <a title="AJG_Vol.109.No.8 page 175" href="http://viewer.zmags.com/publication/7f86916d?page=175"> 1270 Feuerstadt et al. COLON/SMALL BOWEL Ta</a> <a title="AJG_Vol.109.No.8 page 176" href="http://viewer.zmags.com/publication/7f86916d?page=176"> CDI 06–08 vs. 09–11 1271 Table 4. Medicatio</a> <a title="AJG_Vol.109.No.8 page 177" href="http://viewer.zmags.com/publication/7f86916d?page=177"> 1272 Feuerstadt et al. COLON/SMALL BOWEL Ta</a> <a title="AJG_Vol.109.No.8 page 178" href="http://viewer.zmags.com/publication/7f86916d?page=178"> CDI 06–08 vs. 09–11 1273 Table 7. Outcomes </a> <a title="AJG_Vol.109.No.8 page 179" href="http://viewer.zmags.com/publication/7f86916d?page=179"> 1274 Feuerstadt et al. 40% 35%CDI 06–0</a> <a title="AJG_Vol.109.No.8 page 180" href="http://viewer.zmags.com/publication/7f86916d?page=180"> have been a significant difference in 30-day all-</a> <a title="AJG_Vol.109.No.8 page 181" href="http://viewer.zmags.com/publication/7f86916d?page=181"> 1276 Feuerstadt et al. and manuscript wri</a> <a title="AJG_Vol.109.No.8 page 182" href="http://viewer.zmags.com/publication/7f86916d?page=182"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 183" href="http://viewer.zmags.com/publication/7f86916d?page=183"> 1278 Ko et al. PEDIATRICS eosinophilia is f</a> <a title="AJG_Vol.109.No.8 page 184" href="http://viewer.zmags.com/publication/7f86916d?page=184"> HPF in the maximally infiltrated area was conside</a> <a title="AJG_Vol.109.No.8 page 185" href="http://viewer.zmags.com/publication/7f86916d?page=185"> 1280 Ko et al. PEDIATRICS indicating a lack</a> <a title="AJG_Vol.109.No.8 page 186" href="http://viewer.zmags.com/publication/7f86916d?page=186"> Eosinophilic Gastritis in Children 1281 Tab</a> <a title="AJG_Vol.109.No.8 page 187" href="http://viewer.zmags.com/publication/7f86916d?page=187"> 1282 Ko et al. PEDIATRICS HEG and concomita</a> <a title="AJG_Vol.109.No.8 page 188" href="http://viewer.zmags.com/publication/7f86916d?page=188"> in all those with initially elevated counts regar</a> <a title="AJG_Vol.109.No.8 page 189" href="http://viewer.zmags.com/publication/7f86916d?page=189"> 1284 Ko et al. PEDIATRICS our HEG cohort, t</a> <a title="AJG_Vol.109.No.8 page 190" href="http://viewer.zmags.com/publication/7f86916d?page=190"> REFERENCES 1. Powell N, Walker MM, Talley NJ. Ga</a> <a title="AJG_Vol.109.No.8 page 191" href="http://viewer.zmags.com/publication/7f86916d?page=191"> 1286 LETTERS TO THE EDITOR </a> <a title="AJG_Vol.109.No.8 page 192" href="http://viewer.zmags.com/publication/7f86916d?page=192"> neuropeptides from nociceptive nerve fib- ers and</a> <a title="AJG_Vol.109.No.8 page 193" href="http://viewer.zmags.com/publication/7f86916d?page=193"> 1288 Letters to the Editor and will be bet</a> <a title="AJG_Vol.109.No.8 page 194" href="http://viewer.zmags.com/publication/7f86916d?page=194"> We accept the presented argumentation regardin</a> <a title="AJG_Vol.109.No.8 page 195" href="http://viewer.zmags.com/publication/7f86916d?page=195"> 1290 Letters to the Editor is misquoted. “</a> <a title="AJG_Vol.109.No.8 page 196" href="http://viewer.zmags.com/publication/7f86916d?page=196"> and so on). It would be useful to know what proce</a> <a title="AJG_Vol.109.No.8 page 197" href="http://viewer.zmags.com/publication/7f86916d?page=197"> 1292 Letters to the Editor enteritis </a> <a title="AJG_Vol.109.No.8 page 198" href="http://viewer.zmags.com/publication/7f86916d?page=198"> Response to Kumar Morteza Khatibian, MD1, Rasoul</a> <a title="AJG_Vol.109.No.8 page 199" href="http://viewer.zmags.com/publication/7f86916d?page=199"> 1294 Letters to the Editor </a> <a title="AJG_Vol.109.No.8 page 200" href="http://viewer.zmags.com/publication/7f86916d?page=200"> Letters to the Editor 1295 Table 1. Previou</a> <a title="AJG_Vol.109.No.8 page 201" href="http://viewer.zmags.com/publication/7f86916d?page=201"> 1296 Letters to the Editor 10. Ramírez-Lun</a> <a title="AJG_Vol.109.No.8 page 202" href="http://viewer.zmags.com/publication/7f86916d?page=202"> Letters to the Editor 1297 Ethnicity </a> <a title="AJG_Vol.109.No.8 page 203" href="http://viewer.zmags.com/publication/7f86916d?page=203"> 1298 Letters to the Editor All patients we</a> <a title="AJG_Vol.109.No.8 page 204" href="http://viewer.zmags.com/publication/7f86916d?page=204"> nature publishing group </a> <a title="AJG_Vol.109.No.8 page 205" href="http://viewer.zmags.com/publication/7f86916d?page=205"> CLASSIFIEDS www.naturejobs.com Please get in t</a> <a title="AJG_Vol.109.No.8 page 206" href="http://viewer.zmags.com/publication/7f86916d?page=206"> Hawaii's Healthcare Leader Gastroenterologists </a> <a title="AJG_Vol.109.No.8 page 207" href="http://viewer.zmags.com/publication/7f86916d?page=207"> 45 NEW video presentations just added to the ACG</a> <a title="AJG_Vol.109.No.8 page 208" href="http://viewer.zmags.com/publication/7f86916d?page=208"> ScopeGuide Real-time, 3D visualization of the sco</a> <a title="AJG_Vol.109.No.8 page 209" href="http://viewer.zmags.com/publication/7f86916d?page=209"> CRH O'Regan System Non-Surgical Treatment for Hem</a>